Gilead Sciences Inc
MIL:1GILD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gilead Sciences Inc
MIL:1GILD
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FME
|
DE |
|
Empire Metals Ltd
OTC:EPMLF
|
UK |
Wall St Price Targets
1GILD Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for 1GILD is 139.36 EUR with a low forecast of 106.86 EUR and a high forecast of 162.58 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1GILD's stock price target?
Price Target
139.36
EUR
According to Wall Street analysts, the average 1-year price target for 1GILD is 139.36 EUR with a low forecast of 106.86 EUR and a high forecast of 162.58 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 9%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 10%.
